18-63318646-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_000633.3(BCL2):​c.21A>G​(p.Thr7Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.398 in 1,612,024 control chromosomes in the GnomAD database, including 135,183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.32 ( 9647 hom., cov: 32)
Exomes 𝑓: 0.41 ( 125536 hom. )

Consequence

BCL2
NM_000633.3 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.699

Publications

84 publications found
Variant links:
Genes affected
BCL2 (HGNC:990): (BCL2 apoptosis regulator) This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 18-63318646-T-C is Benign according to our data. Variant chr18-63318646-T-C is described in ClinVar as Benign. ClinVar VariationId is 3060318.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.699 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCL2NM_000633.3 linkc.21A>G p.Thr7Thr synonymous_variant Exon 2 of 3 ENST00000333681.5 NP_000624.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCL2ENST00000333681.5 linkc.21A>G p.Thr7Thr synonymous_variant Exon 2 of 3 1 NM_000633.3 ENSP00000329623.3

Frequencies

GnomAD3 genomes
AF:
0.318
AC:
48421
AN:
152080
Hom.:
9644
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0808
Gnomad AMI
AF:
0.523
Gnomad AMR
AF:
0.391
Gnomad ASJ
AF:
0.349
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.344
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.354
GnomAD2 exomes
AF:
0.372
AC:
91756
AN:
246918
AF XY:
0.378
show subpopulations
Gnomad AFR exome
AF:
0.0754
Gnomad AMR exome
AF:
0.415
Gnomad ASJ exome
AF:
0.351
Gnomad EAS exome
AF:
0.0968
Gnomad FIN exome
AF:
0.459
Gnomad NFE exome
AF:
0.427
Gnomad OTH exome
AF:
0.403
GnomAD4 exome
AF:
0.406
AC:
593323
AN:
1459826
Hom.:
125536
Cov.:
65
AF XY:
0.407
AC XY:
295512
AN XY:
726246
show subpopulations
African (AFR)
AF:
0.0680
AC:
2271
AN:
33418
American (AMR)
AF:
0.414
AC:
18451
AN:
44572
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
9046
AN:
26076
East Asian (EAS)
AF:
0.105
AC:
4153
AN:
39480
South Asian (SAS)
AF:
0.368
AC:
31727
AN:
86176
European-Finnish (FIN)
AF:
0.459
AC:
24325
AN:
53038
Middle Eastern (MID)
AF:
0.390
AC:
2247
AN:
5764
European-Non Finnish (NFE)
AF:
0.431
AC:
478709
AN:
1110988
Other (OTH)
AF:
0.371
AC:
22394
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
21904
43809
65713
87618
109522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14230
28460
42690
56920
71150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.318
AC:
48426
AN:
152198
Hom.:
9647
Cov.:
32
AF XY:
0.320
AC XY:
23836
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0805
AC:
3347
AN:
41568
American (AMR)
AF:
0.391
AC:
5982
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
1212
AN:
3470
East Asian (EAS)
AF:
0.101
AC:
525
AN:
5182
South Asian (SAS)
AF:
0.346
AC:
1670
AN:
4822
European-Finnish (FIN)
AF:
0.457
AC:
4837
AN:
10592
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29523
AN:
67964
Other (OTH)
AF:
0.350
AC:
737
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1537
3075
4612
6150
7687
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
22062
Bravo
AF:
0.303
Asia WGS
AF:
0.202
AC:
705
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

BCL2-related disorder Benign:1
Oct 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
8.2
DANN
Benign
0.77
PhyloP100
0.70
PromoterAI
-0.00050
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801018; hg19: chr18-60985879; COSMIC: COSV61374121; API